These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 1389948)

  • 1. The use of cimetidine to reduce dapsone-dependent methaemoglobinaemia in dermatitis herpetiformis patients.
    Coleman MD; Rhodes LE; Scott AK; Verbov JL; Friedmann PS; Breckenridge AM; Park BK
    Br J Clin Pharmacol; 1992 Sep; 34(3):244-9. PubMed ID: 1389948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cimetidine improves the therapeutic/toxic ratio of dapsone in patients on chronic dapsone therapy.
    Rhodes LE; Tingle MD; Park BK; Chu P; Verbov JL; Friedmann PS
    Br J Dermatol; 1995 Feb; 132(2):257-62. PubMed ID: 7888363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of dapsone-induced methaemoglobinaemia by cimetidine in the rat during chronic dapsone administration.
    Coleman MD; Tingle MD; Park BK
    J Pharm Pharmacol; 1991 Mar; 43(3):186-90. PubMed ID: 1675276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of dapsone-induced methaemoglobinaemia by cimetidine in the presence of trimethoprim in the rat.
    Coleman MD; Russell RM; Tingle MD; Park BK
    J Pharm Pharmacol; 1992 Feb; 44(2):114-8. PubMed ID: 1352810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of cimetidine as a selective inhibitor of dapsone N-hydroxylation in man.
    Coleman MD; Scott AK; Breckenridge AM; Park BK
    Br J Clin Pharmacol; 1990 Nov; 30(5):761-7. PubMed ID: 2271376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High dose dapsone toxicity.
    Shelley WB; Goldwein MI
    Br J Dermatol; 1976 Jul; 95(1):79-82. PubMed ID: 952745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of dapsone-induced methaemoglobinaemia in the rat isolated perfused liver.
    Coleman MD; Hoaksey PE; Breckenridge AM; Park BK
    J Pharm Pharmacol; 1990 May; 42(5):302-7. PubMed ID: 1976775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Case of iatrogenic methemoglobinemia (due to 4,4-diamino-diphenylsulfone)].
    Riceputi G; Biagioli R; Guardigni L; Dradi C; Pretolani E; Fabbri F
    G Clin Med; 1979 Jun; 60(6):454-8. PubMed ID: 467879
    [No Abstract]   [Full Text] [Related]  

  • 9. Methemoglobinemia associated with the ingestion of Diasone.
    Fisher I; Orkin M
    Arch Dermatol; 1965 Sep; 92(3):327. PubMed ID: 11851261
    [No Abstract]   [Full Text] [Related]  

  • 10. The incidence of agranulocytosis during treatment of dermatitis herpetiformis with dapsone as reported in Sweden, 1972 through 1988.
    Hörnsten P; Keisu M; Wiholm BE
    Arch Dermatol; 1990 Jul; 126(7):919-22. PubMed ID: 2360840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Agranulocytosis induced by dapsone prescribed for dermatitis herpetiformis].
    Machet L; Callens A; Mercier E; Gargot S; Lorette G; Vaillant L
    Ann Dermatol Venereol; 1996; 123(5):328-30. PubMed ID: 8761086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dapsone-induced blood dyscrasia in the mouse: evidence for the role of an active metabolite.
    Ahmadi M; Khalaf LF; Smith HJ; Nicholls PJ
    J Pharm Pharmacol; 1996 Feb; 48(2):228-32. PubMed ID: 8935178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic use of dapsone in dermatitis herpetiformis (Duhring) and in certain inflammatory skin diseases].
    Révész K; Schneider I
    Orv Hetil; 1995 Jan; 136(2):59-62. PubMed ID: 7862431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of sulfones in the treatment of dermatitis herpetiformis with particular reference to adverse effects].
    Pawlik H; Placek W; Kwietniak K
    Przegl Dermatol; 1980; 67(2):221-7. PubMed ID: 6996039
    [No Abstract]   [Full Text] [Related]  

  • 15. The protective effect of vitamin E on the hemolysis associated with dapsone treatment in patients with dermatitis herpetiformis.
    Prussick R; Ali MA; Rosenthal D; Guyatt G
    Arch Dermatol; 1992 Feb; 128(2):210-3. PubMed ID: 1739299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between dapsone dose, serum concentration and disease severity in dermatitis herpetiformis.
    Sanders SW; Zone JJ
    Arzneimittelforschung; 1986; 36(1):146-9. PubMed ID: 3954818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An unusual cause of cyanosis in a patient with COPD.
    Chang YJ; Ali H; Draper A; Chua F
    BMJ Case Rep; 2013 Mar; 2013():. PubMed ID: 23456158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cimetidine and dapsone-mediated methaemoglobinaemia.
    Mehta M
    Anaesthesia; 2007 Nov; 62(11):1188. PubMed ID: 17924910
    [No Abstract]   [Full Text] [Related]  

  • 19. Dapsone-induced acute pancreatitis.
    Jha SH; Reddy JA; Dave JK
    Ann Pharmacother; 2003 Oct; 37(10):1438-40. PubMed ID: 14519046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum hemopexin in patients with dermatitis herpetiformis on dapsone (di(4-aminophenyl)sulphone).
    Kastrup W; Lindstedt G; Lundberg PA; Mobacken H
    Arch Dermatol Res (1975); 1975 Dec; 254(3):225-32. PubMed ID: 1211972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.